EWTX EDGEWISE THERAPEUTICS INC More: the full row for EDGEWISE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,000,000 shares; 2025Q1: 5,350,000 shares; 2025Q2: 5,350,000 shares; 2025Q3: 5,350,000 shares; 2025Q4: 5,350,000 shares; 2026Q1: 5,350,000 shares; 2026Q2: 5,350,000 shares; 2026Q3: 5,350,000 shares 5,350,000 $217M 14.58% 0 Timeline ASML ASML HLDG NV More: the full row for ASML HLDG NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 165,836 shares; 2025Q1: 165,836 shares; 2025Q2: 165,836 shares; 2025Q3: 145,836 shares; 2025Q4: 113,946 shares; 2026Q1: 94,946 shares; 2026Q2: 94,946 shares; 2026Q3: 94,946 shares 94,946 $172M 11.55% 0 Timeline BN BROOKFIELD CORP More: the full row for BROOKFIELD CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,798,830 shares; 2025Q1: 2,330,830 shares; 2025Q2: 2,330,830 shares; 2025Q3: 2,330,830 shares; 2025Q4: 3,496,245 shares; 2026Q1: 3,496,245 shares; 2026Q2: 3,496,245 shares; 2026Q3: 4,465,035 shares 4,465,035 $163M 10.93% +968,790 Timeline COAG HEMAB THERAPEUTICS HLDGS INC More: the full row for HEMAB THERAPEUTICS HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,180,550 shares; 2026Q3: 4,180,550 shares 4,180,550 $129M 8.65% 0 Timeline AVLN AVALYN PHARMACEUTICALS INC More: the full row for AVALYN PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,883,289 shares; 2026Q3: 3,449,191 shares 3,449,191 $98.3M 6.6% -434,098 Timeline MIRM MIRUM PHARMACEUTICALS INC More: the full row for MIRUM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,500,000 shares; 2025Q1: 1,500,000 shares; 2025Q2: 1,500,055 shares; 2025Q3: 1,264,028 shares; 2025Q4: 1,264,028 shares; 2026Q1: 1,325,000 shares; 2026Q2: 1,125,000 shares; 2026Q3: 1,125,000 shares 1,125,000 $96.2M 6.46% 0 Timeline CRM SALESFORCE INC More: the full row for SALESFORCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 293,901 shares; 2025Q1: 272,801 shares; 2025Q2: 330,187 shares; 2025Q3: 330,187 shares; 2025Q4: 330,187 shares; 2026Q1: 393,187 shares; 2026Q2: 393,187 shares; 2026Q3: 393,187 shares 393,187 $90.3M 6.06% 0 Timeline ELVN ENLIVEN THERAPEUTICS INC More: the full row for ENLIVEN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,084,432 shares; 2025Q3: 1,426,260 shares; 2025Q4: 1,480,000 shares; 2026Q1: 1,280,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 1,000,000 shares 1,000,000 $45.8M 3.08% 0 Timeline FDMT 4D MOLECULAR THERAPEUTICS IN More: the full row for 4D MOLECULAR THERAPEUTICS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,500,000 shares; 2025Q1: 1,950,000 shares; 2025Q2: 2,000,000 shares; 2025Q3: 2,000,000 shares; 2025Q4: 3,650,737 shares; 2026Q1: 3,650,737 shares; 2026Q2: 3,249,178 shares; 2026Q3: 3,000,000 shares 3,000,000 $42.9M 2.88% -249,178 Timeline OBX OBSIDIAN THERAPEUTICS INC More: the full row for OBSIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 3,123,992 shares 3,123,992 $42.9M 2.88% new Timeline PCVX VAXCYTE INC More: the full row for VAXCYTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 750,000 shares; 2025Q1: 915,000 shares; 2025Q2: 916,160 shares; 2025Q3: 916,160 shares; 2025Q4: 916,160 shares; 2026Q1: 860,000 shares; 2026Q2: 800,000 shares; 2026Q3: 710,000 shares 710,000 $40.4M 2.71% -90,000 Timeline FND FLOOR & DECOR HLDGS INC More: the full row for FLOOR & DECOR HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 797,000 shares; 2026Q3: 797,000 shares 797,000 $36.5M 2.45% 0 Timeline VRDN VIRIDIAN THERAPEUTICS INC More: the full row for VIRIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,250,000 shares; 2025Q1: 2,250,300 shares; 2025Q2: 2,380,000 shares; 2025Q3: 2,380,000 shares; 2025Q4: 2,380,000 shares; 2026Q1: 2,000,000 shares; 2026Q2: 2,135,000 shares; 2026Q3: 1,750,000 shares 1,750,000 $36M 2.42% -385,000 Timeline AVBP ARRIVENT BIOPHARMA INC More: the full row for ARRIVENT BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,520,627 shares; 2025Q1: 1,872,142 shares; 2025Q2: 1,872,142 shares; 2025Q3: 1,942,142 shares; 2025Q4: 1,942,142 shares; 2026Q1: 1,942,142 shares; 2026Q2: 1,500,000 shares; 2026Q3: 1,175,000 shares 1,175,000 $35.6M 2.39% -325,000 Timeline INSM INSMED INC More: the full row for INSMED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 724,666 shares; 2025Q1: 724,666 shares; 2025Q2: 680,000 shares; 2025Q3: 200,000 shares; 2025Q4: 200,000 shares; 2026Q1: not reported; 2026Q2: 120,723 shares; 2026Q3: 284,425 shares 284,425 $32.5M 2.18% +163,702 Timeline PHVS PHARVARIS N V More: the full row for PHARVARIS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,725,000 shares; 2025Q1: 1,725,000 shares; 2025Q2: 1,725,000 shares; 2025Q3: 1,750,000 shares; 2025Q4: 1,750,000 shares; 2026Q1: 1,750,000 shares; 2026Q2: 1,400,000 shares; 2026Q3: 1,019,426 shares 1,019,426 $32.3M 2.17% -380,574 Timeline CLDX CELLDEX THERAPEUTICS INC NEW More: the full row for CELLDEX THERAPEUTICS INC NEW Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,000,000 shares; 2025Q1: 1,200,000 shares; 2025Q2: 1,200,000 shares; 2025Q3: 1,200,000 shares; 2025Q4: 1,200,000 shares; 2026Q1: 1,200,000 shares; 2026Q2: 1,025,000 shares; 2026Q3: 950,000 shares 950,000 $30.8M 2.07% -75,000 Timeline BABA ALIBABA GROUP HLDG LTD More: the full row for ALIBABA GROUP HLDG LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 452,327 shares; 2025Q1: 372,327 shares; 2025Q2: 372,327 shares; 2025Q3: 257,327 shares; 2025Q4: 257,327 shares; 2026Q1: 257,327 shares; 2026Q2: 257,327 shares; 2026Q3: 257,327 shares 257,327 $27.7M 1.86% 0 Timeline XENE XENON PHARMACEUTICALS INC More: the full row for XENON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 485,438 shares; 2026Q2: 485,438 shares; 2026Q3: 652,105 shares 652,105 $24.3M 1.63% +166,667 Timeline SRRK SCHOLAR ROCK HLDG CORP More: the full row for SCHOLAR ROCK HLDG CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 460,002 shares 460,002 $22.2M 1.49% new Timeline DYN DYNE THERAPEUTICS INC More: the full row for DYNE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 960,394 shares; 2026Q3: 1,376,164 shares 1,376,164 $22.2M 1.49% +415,770 Timeline MPLT MAPLIGHT THERAPEUTICS INC More: the full row for MAPLIGHT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,686,622 shares; 2026Q1: 3,686,622 shares; 2026Q2: 3,686,622 shares; 2026Q3: 2,086,622 shares 2,086,622 $21.3M 1.43% -1,600,000 Timeline CTNM CONTINEUM THERAPEUTICS INC More: the full row for CONTINEUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 704,013 shares 704,013 $9.45M 0.63% new Timeline ALMS ALUMIS INC More: the full row for ALUMIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,100,000 shares; 2026Q3: 1,250,000 shares 1,250,000 $9.24M 0.62% +150,000 Timeline BBOT BRIDGEBIO ONCOLOGY THERAPEUT More: the full row for BRIDGEBIO ONCOLOGY THERAPEUT Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,961,317 shares; 2025Q4: 1,961,317 shares; 2026Q1: 2,185,923 shares; 2026Q2: 2,250,000 shares; 2026Q3: 2,250,000 shares 2,250,000 $9.22M 0.62% 0 Timeline MQ MARQETA INC More: the full row for MARQETA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 441,558 shares; 2025Q1: 441,558 shares; 2025Q2: 441,558 shares; 2025Q3: 441,558 shares; 2025Q4: 441,558 shares; 2026Q1: 441,558 shares; 2026Q2: 441,558 shares; 2026Q3: 110,389 shares 110,389 $1.88M 0.13% -331,169 Timeline LNZA LANZATECH GLOBAL INC More: the full row for LANZATECH GLOBAL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 158,148 shares; 2025Q4: 158,148 shares; 2026Q1: 158,148 shares; 2026Q2: 158,148 shares; 2026Q3: 158,148 shares 158,148 $903K 0.06% 0 Timeline